The Future of Psychedelic Medicine

Our Story

Find out what inspires us to support mental health disorders.

Our Mission

Supporting innovative therapies to help humans thrive.

Our Team

Multi-Disciplinary Collaboration
creating positive experiences and outcomes.

Mission

Using a foundation of evidence-informed research, we want to empower people to achieve their potential and thrive.

CORE PILLARS

HAVN Labs

Psychedelic medicine is the frontier of mental health and wellness

Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.


350 Million

People globally are affected by a form of depression.

1 Trillion

Dollars lost annually in global workforce productivity due to depression and anxiety.

0

Formulas standardized across clinical studies of psychedelic compounds.

Havn Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.

Press Releases

Havn Labs Jamaica Facility Now Fully Operational

The Company has started production of its first grow with local partner Hypha Wellness. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) …

Read More →
Press Releases

Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division

The Facility acquisition positions Havn Life to quickly expand its product portfolio and reach additional NHP categories. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) …

Read More →
Press Releases

Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness

Havn Life believes operations can advance its business plan and potentially accelerate production of naturally-derived psilocybin for global medical research. Vancouver, BC – Havn Life …

Read More →
Scroll to Top